Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation in adults with relapsed/refractory non-Hodgkin lymphoma.
Nishikubo M, Shimomura Y, Nakaya Y, Shinohara A, Uchida N, Takayama N, Kobayashi H, Uehara Y, Ishikawa J, Ishiwata K, Hiramoto N, Nakazawa H, Kataoka K, Kanda J, Nagafuji K, Kozai Y, Matsuhashi Y, Ishimaru F, Kim SW, Fukuda T, Kanda Y, Atsuta Y, Kondo E, Kako S. Nishikubo M, et al. Among authors: kanda j, kanda y. Bone Marrow Transplant. 2024 Dec;59(12):1735-1743. doi: 10.1038/s41409-024-02423-y. Epub 2024 Sep 25. Bone Marrow Transplant. 2024. PMID: 39322651
Limited efficacy of lamivudine against hepatitis B virus infection in allogeneic hematopoietic stem cell transplant recipients.
Ohnishi M, Kanda Y, Takeuchi T, Won Kim S, Hori A, Niiya H, Chizuka A, Nakai K, Saito T, Makimoto A, Tanosaki R, Watanabe T, Kobayashi Y, Tobinai K, Takaue Y, Mineishi S. Ohnishi M, et al. Among authors: kanda y. Transplantation. 2002 Mar 15;73(5):812-5. doi: 10.1097/00007890-200203150-00027. Transplantation. 2002. PMID: 11907433
Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
Nakai K, Mineishi S, Kami M, Saito T, Hori A, Kojima R, Imataki O, Hamaki T, Yoshihara S, Ohnishi M, Kim SW, Ando T, Fumitoh A, Kanda Y, Makimoto A, Tanosaki R, Kanai S, Heike Y, Ohnishi T, Kawano Y, Wakasugi H, Takaue Y. Nakai K, et al. Among authors: kanda y. Transplantation. 2003 Jun 27;75(12):2135-43. doi: 10.1097/01.TP.0000066453.32263.F7. Transplantation. 2003. PMID: 12829926
A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease.
Hori A, Kanda Y, Goyama S, Onishi Y, Komeno Y, Mitani K, Kishi Y, Ogawa S, Imataki O, Chiba S, Kojima R, Hamaki T, Sakiyama M, Kami M, Makimoto A, Tanosaki R, Takaue Y, Hirai H; Japan Hematology and Oncology Clinical Study Group. Hori A, et al. Among authors: kanda y. Transplantation. 2005 Feb 15;79(3):372-4. doi: 10.1097/01.tp.0000151001.64189.1d. Transplantation. 2005. PMID: 15699774 Clinical Trial.
In vivo alemtuzumab enables haploidentical human leukocyte antigen-mismatched hematopoietic stem-cell transplantation without ex vivo graft manipulation.
Kanda Y, Oshima K, Asano-Mori Y, Kandabashi K, Nakagawa M, Sakata-Yanagimoto M, Izutsu K, Hangaishi A, Tsujino S, Ogawa S, Motokura T, Chiba S, Hirai H. Kanda Y, et al. Transplantation. 2005 May 27;79(10):1351-7. doi: 10.1097/01.tp.0000158718.49286.14. Transplantation. 2005. PMID: 15912103 Clinical Trial.
Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients.
Narimatsu H, Matsumura T, Kami M, Miyakoshi S, Kusumi E, Takagi S, Miura Y, Kato D, Inokuchi C, Myojo T, Kishi Y, Murashige N, Yuji K, Masuoka K, Yoneyama A, Wake A, Morinaga S, Kanda Y, Taniguchi S. Narimatsu H, et al. Among authors: kanda y. Biol Blood Marrow Transplant. 2005 Jun;11(6):429-36. doi: 10.1016/j.bbmt.2005.01.010. Biol Blood Marrow Transplant. 2005. PMID: 15931631 Free article.
Early immune reaction after reduced-intensity cord-blood transplantation for adult patients.
Kishi Y, Kami M, Miyakoshi S, Kanda Y, Murashige N, Teshima T, Kusumi E, Hara S, Matsumura T, Yuji K, Masuoka K, Wake A, Morinaga S, Kanemaru M, Hayashi T, Tanaka Y, Taniguchi S; Tokyo Stem Cell Transplant Consortium. Kishi Y, et al. Among authors: kanda y. Transplantation. 2005 Jul 15;80(1):34-40. doi: 10.1097/01.tp.0000163289.20406.86. Transplantation. 2005. PMID: 16003230
Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms.
Murashige N, Kami M, Kishi Y, Kim SW, Takeuchi M, Matsue K, Kanda Y, Hirokawa M, Kawabata Y, Matsumura T, Kusumi E, Hirabayashi N, Nagafuji K, Suzuki R, Takeuchi K, Oshimi K. Murashige N, et al. Among authors: kanda y. Br J Haematol. 2005 Aug;130(4):561-7. doi: 10.1111/j.1365-2141.2005.05651.x. Br J Haematol. 2005. PMID: 16098071 Free article.
A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donors.
Komeno Y, Kanda Y, Hamaki T, Mitani K, Iijima K, Ueyama J, Yoshihara S, Yuji K, Kim SW, Ando T, Kami M, Yamamoto E, Hiruma K, Mori S, Hirai H, Sakamaki H; Japan Hematology and Oncology Clinical Study Group. Komeno Y, et al. Among authors: kanda y. Biol Blood Marrow Transplant. 2006 Apr;12(4):408-13. doi: 10.1016/j.bbmt.2005.11.007. Biol Blood Marrow Transplant. 2006. PMID: 16545724 Free article. Clinical Trial.
1,415 results